This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Stuart D Ibsen in Biomarker Analysis
Introduction
Stuart D Ibsen is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of biomarker analysis through his innovative patent. His work focuses on the development of miniaturized electronic systems that enhance the efficiency of biomarker isolation and analysis.
Latest Patents
Stuart D Ibsen holds a patent for "Electrokinetic microelectrode devices and methods for biomarker analysis." This patent discloses miniaturized electronic systems, devices, and methods that can be incorporated into blood collection tubes and other containers. These innovations enable the immediate isolation, concentration, analysis, and storage of disease-related biomarkers upon blood draw. The miniaturized electronic system includes a high-surface area folded or sandwiched electrokinetic microelectrode array chip device. This device allows both AC dielectrophoretic (DEP) and DC electrophoretic-based separation and isolation processes to be utilized for the concentration of biomarkers.
Career Highlights
Throughout his career, Ibsen has focused on advancing technologies that improve medical diagnostics. His innovative approach to biomarker analysis has the potential to revolutionize how diseases are detected and monitored.
Collaborations
Ibsen has collaborated with notable individuals in his field, including Michael J Heller and Daniel Heineck. These partnerships have contributed to the development and refinement of his patented technologies.
Conclusion
Stuart D Ibsen's work in the field of biomarker analysis exemplifies the impact of innovative thinking on medical technology. His patent for electrokinetic microelectrode devices represents a significant advancement in the ability to analyze biomarkers efficiently.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
